The effect of targeted therapy on overall survival in advanced renal cancer: a study of the national surveillance epidemiology and end results registry database
U Vaishampayan, H Vankayala, FD Vigneau… - Clinical genitourinary …, 2014 - Elsevier
Introduction With the advent and availability of targeted therapy, the treatment of
advanced/metastatic renal cell carcinoma (RCC) underwent a drastic change in 2005. The
effect of this change on clinical outcome within the population has not been studied. The aim
of this study was to evaluate the overall survival (OS), before, and after availability of
targeted therapy, for advanced RCC cases in the population-based Surveillance,
Epidemiology, and End Results (SEER) cancer registry. Materials and Methods All …
advanced/metastatic renal cell carcinoma (RCC) underwent a drastic change in 2005. The
effect of this change on clinical outcome within the population has not been studied. The aim
of this study was to evaluate the overall survival (OS), before, and after availability of
targeted therapy, for advanced RCC cases in the population-based Surveillance,
Epidemiology, and End Results (SEER) cancer registry. Materials and Methods All …
以上显示的是最相近的搜索结果。 查看全部搜索结果